Clinical Trials Directory

We are doing this study to find out if images taken of the eye using a special type of camera placed inside a surgical microscope, called Microscope Integrated Optical Coherence Tomography (MIOCT), will give us new information during surgery that will improve both how we perform eye surgery and the results of surgery.

We are using this registry to learn more about acute aortic dissection from hospitals across the country.

We are doing this study to learn more about prostate cancer and whether certain treatments are related with different outcomes and patient experiences.

We are doing this study to find out if an experimental drug combination made up of ivosidenib, gemcitabine, cisplatin, and durvalumab is a safe and effective for treating cholangiocarcinoma.

This study has 3 parts: 1. Screening - Lasts up to 28 days. You'll get heart tests, scans, and blood and urine tests. 2. Treatment - You'll be randomly picked to get either a new medicine (iza-bren) or a cancer medicine your doctor chooses. You'll visit the clinic 2-3 times every few weeks. 3. Follow-up - After treatment ends, you'll have: - A safety check 30 days later - Regular checkups every 12 weeks - More tests like scans and heart checks

We are doing this study to find out if the drugs talquetamab and teclistamab are a safe and effective option for people with multiple myeloma that has come back after treatment (relapsed) or is not improving with treatment (refractory).

We are doing this study to find out if the study drug JCAR017 is safe and to find out what dose is recommended for patients with relapsed/refractory CLL or SLL.